Takeda's Patent Infringement Suit Not Antitrust-Proof
Patent infringement lawsuits challenging generic drug applications aren't automatically immune from antitrust claims, a New Jersey federal judge ruled Wednesday, refusing to toss counterclaims accusing Takeda Pharmaceutical Co. Ltd. of trying...To view the full article, register now.
Already a subscriber? Click here to view full article